Halline A G, Dudeja P K, Brasitus T A
Department of Medicine, University of Chicago, IL.
Biochim Biophys Acta. 1989 Jul 21;992(1):106-14. doi: 10.1016/0304-4165(89)90056-1.
Recently, our laboratory has demonstrated that N1-acetylspermidine levels were increased in the distal colonic mucosa of rats administered 1,2-dimethylhydrazine for 15 and 26 weeks. In order to further explore the possible role of this acetylated polyamine in the malignant transformation process induced by this carcinogen, groups of rats were subcutaneously injected weekly with dimethylhydrazine (20 mg/kg body wt.) or diluent for 5, 10, 15 and 26 weeks +/- 1% 2-difluoromethylornithine in the drinking water. The latter agent, an irreversible inhibitor of ornithine decarboxylase, has previously been shown to inhibit colonic tumor formation in this experimental model. At each of these time periods, rats from each group were killed, their proximal and distal colonic mucosa harvested and examined, and compared with respect to polyamine levels, including N1-acetylspermidine, as well as the activities of ornithine decarboxylase, S-adenosylmethionine decarboxylase, spermidine N1-acetyltransferase and polyamine oxidase. The results of these experiments demonstrated that: (1) N1-acetylspermidine levels in the proximal colonic segment of all animals were similar at each time point; (2) N1-acetylspermidine levels were also similar in the distal colons of all animals at 5 and 10 weeks. At 15 weeks, however, the level of N1-acetylspermidine was increased in the dimethylhydrazine-treated distal colonic segment secondary to increases in the activity of spermidine N1-acetyltransferase; and (3) at 26 weeks, the level of this acetylated polyamine remained higher in dimethylhydrazine-treated distal 'uninvolved' colonic mucosa and was markedly elevated in colonic tumors; (4) co-administration of difluoromethylornithine decreased the elevated levels of N1-acetylspermidine to control values in the distal colons of animals treated with carcinogen for 15 and 26 weeks; and (5) difluoromethylornithine markedly reduced the number of tumors induced by dimethylhydrazine in the distal but not proximal colonic mucosa at 26 weeks.
最近,我们实验室已证明,给予1,2 - 二甲基肼15周和26周的大鼠,其远端结肠黏膜中的N1 - 乙酰亚精胺水平升高。为了进一步探究这种乙酰化多胺在该致癌物诱导的恶性转化过程中的可能作用,将大鼠分组,每周皮下注射二甲基肼(20毫克/千克体重)或稀释剂,持续5、10、15和26周,同时在饮用水中添加或不添加1%的2 - 二氟甲基鸟氨酸。后一种试剂是鸟氨酸脱羧酶的不可逆抑制剂,此前已证明在该实验模型中可抑制结肠肿瘤形成。在每个时间段,每组大鼠均处死,采集并检查其近端和远端结肠黏膜,比较多胺水平,包括N1 - 乙酰亚精胺,以及鸟氨酸脱羧酶、S - 腺苷甲硫氨酸脱羧酶、亚精胺N1 - 乙酰转移酶和多胺氧化酶的活性。这些实验结果表明:(1)在每个时间点,所有动物近端结肠段的N1 - 乙酰亚精胺水平相似;(2)在5周和10周时,所有动物远端结肠中的N1 - 乙酰亚精胺水平也相似。然而,在15周时,由于亚精胺N1 - 乙酰转移酶活性增加,二甲基肼处理的远端结肠段中N1 - 乙酰亚精胺水平升高;(3)在26周时,这种乙酰化多胺在二甲基肼处理的远端“未受累”结肠黏膜中水平仍然较高,在结肠肿瘤中显著升高;(4)同时给予二氟甲基鸟氨酸可将致癌物处理15周和26周的动物远端结肠中升高的N1 - 乙酰亚精胺水平降至对照值;(5)在26周时,二氟甲基鸟氨酸显著减少了二甲基肼在远端而非近端结肠黏膜中诱导的肿瘤数量。